Pharmaceutical anti-counterfeiting : combating the real danger from fake drugs / (Record no. 205184)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05332cam a2200805Ia 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn745970855 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20171116140158.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 101020s2011 njua ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118023679 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1118023676 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118023655 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 111802365X |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118023662 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1118023668 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780470616178 |
| Qualifying information | (Cloth) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 0470616172 |
| Qualifying information | (Cloth) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 1283175665 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781283175661 |
| 024 8# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 9786613175663 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000049641635 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV041911509 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBSZ |
| System control number | 430989806 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBSZ |
| System control number | 449240444 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 14693210 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | SE4M6 |
| System control number | 120058359 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV043393342 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)745970855 |
| Canceled/invalid control number | (OCoLC)743204852 |
| -- | (OCoLC)746324257 |
| -- | (OCoLC)747412618 |
| -- | (OCoLC)747427281 |
| -- | (OCoLC)791305549 |
| -- | (OCoLC)811493653 |
| -- | (OCoLC)816850646 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 317566 |
| Source of stock number/acquisition | MIL |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | CDX |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | CDX |
| Modifying agency | IDEBK |
| -- | DG1 |
| -- | E7B |
| -- | YDXCP |
| -- | N$T |
| -- | OCLCQ |
| -- | MYG |
| -- | OCLCQ |
| -- | OCLCA |
| -- | OCLCF |
| -- | OCLCQ |
| -- | NLGGC |
| -- | OCLCQ |
| -- | DEBSZ |
| -- | MHW |
| -- | UKDOC |
| -- | DEBBG |
| -- | OCLCQ |
| -- | N$T |
| -- | OCLCQ |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | HD9665.5 |
| Item number | .D38 2011eb |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QV 773 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 023000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 058170 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 072000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1068/4 |
| Edition number | 22 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Davison, Mark, |
| Dates associated with a name | 1968 March 1- |
| 245 10 - TITLE STATEMENT | |
| Title | Pharmaceutical anti-counterfeiting : combating the real danger from fake drugs / |
| Statement of responsibility, etc. | Mark Davison. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Hoboken, N.J. : |
| Name of publisher, distributor, etc. | John Wiley & Sons, |
| Date of publication, distribution, etc. | ©2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xxiii, 402 pages) : |
| Other physical details | illustrations |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Frontmatter -- General Themes. Introduction -- Origins and Context of Counterfeiting in Healthcare -- A Snapshot of the Problem -- Risks and Costs of Counterfeit Pharmaceuticals -- Anti-Counterfeiting Definitions -- Protecting and Educating Consumers -- Business Risks and Strategy -- Government Issues -- Intellectual Property and Anti-Counterfeiting -- Traceability or Authentication? -- Authentication. What is Authentication? -- Authentication of the Person -- Authentication of Bulk Products -- On-Dose and In-Dose Authentication -- Analytical Detection of Counterfeit Dosage Forms -- The Role of Packaging -- Printing Technologies -- Security Labels -- Holograms and DOVIDs -- Specialty Inks -- Covert Taggants and Forensic Markers -- General Conclusions on Printed Packaging and Security Labels -- Security of Primary Packaging -- Security of Secondary Packaging -- Analytical Methods for Packaging -- Security of Other Packaging Types -- Bulk Packaging and Transport Security -- Product Tracking. Rationale for Pharmaceutical Tracking -- Tracking Technologies -- Data Format, Generation, and Storage -- Management of Packaging Hierarchy -- Geographical Perspectives -- Product Tracking in Other Industries -- Supply Chain Security Processes -- Implementing Anti-Counterfeiting Initiatives-Practical Issues -- Conclusions and the Future. Where do we go from here? -- New Models, New Approaches -- Selected Examples from around the World -- Further Resources. A Patient's Guide to Avoiding Counterfeit Drugs -- Notes and References -- Glossary -- Further Resources. Information Sources -- Drug Regulators. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Product counterfeiting. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug adulteration. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Contamination. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Consumer Product Safety. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Fraud |
| General subdivision | prevention & control. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical Preparations |
| General subdivision | standards. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug adulteration. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Product counterfeiting. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Drug Guides. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Nursing |
| -- | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacy. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug adulteration. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst00898652 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Product counterfeiting. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst01078205 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| International Standard Book Number | 9786613175663 |
| Record control number | (DLC) 2010044590 |
| -- | (OCoLC)671465412 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://onlinelibrary.wiley.com/book/10.1002/9781118023679 |
| Public note | Wiley Online Library |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Books |
No items available.